(Q40052629)

16 September 2017

Hypermethylation of the somatostatin promoter is a common, early event in human esophageal carcinogenesis (English)

1 reference

16 September 2017

1 reference

1 reference

Zhe Jin

1

1 reference

16 September 2017

Yuriko Mori

2

1 reference

16 September 2017

James P Hamilton

3

1 reference

16 September 2017

Alexandru Olaru

4

1 reference

16 September 2017

Fumiaki Sato

5

1 reference

16 September 2017

Jian Yang

6

1 reference

16 September 2017

Tetsuo Ito

7

1 reference

16 September 2017

Takatsugu Kan

8

1 reference

16 September 2017

Rachana Agarwal

9

1 reference

16 September 2017

Stephen J Meltzer

10

1 reference

16 September 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

16 September 2017

1 reference

16 September 2017

112

1 reference

16 September 2017

1

1 reference

16 September 2017

43-49

1 reference

Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk

16 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23135

Roles of cell division and gene transcription in the methylation of CpG islands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23135

The meaning and use of the area under a receiver operating characteristic (ROC) curve

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23135

Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23135

21 January 2018

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23135

7 January 2021

Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23135

7 January 2021

Somatostatin and its receptor family

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23135

7 January 2021

Somatostatin analogs for diagnosis and treatment of cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23135

7 January 2021

Lipophilization of somatostatin analog RC-160 with long chain fatty acid improves its antiproliferative and antiangiogenic activity in vitro

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23135

7 January 2021

Somatostatin, its receptors and analogs, in lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23135

7 January 2021

N-terminal acylation of somatostatin analog with long chain fatty acids enhances its stability and anti-proliferative activity in human breast adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23135

7 January 2021

Gene silencing in cancer in association with promoter hypermethylation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23135

7 January 2021

A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23135

7 January 2021

Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23135

7 January 2021

Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23135

7 January 2021

Oesophageal cancer incidence and mortality in patients with long-segment Barrett's oesophagus after a mean follow-up of 12.7 years

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23135

7 January 2021

The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23135

7 January 2021

Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23135

7 January 2021

Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23135

7 January 2021

Identifiers

DOI

10.1002/CNCR.23135

1 reference

16 September 2017

1 reference